Medinfo Issue#18

Page 30

MEDINFO Spring 2013

International Market & Trends

Global medical R & D new hot spot for a new generation of Implantable Medical Devices

I

mplantable medical device industry has

cancer and other malignancies in patients

can be more accurate, more complete

made remarkable progress in the past

in vivo, active in a large number of tumor

information, which can guide insulin doses and

30 years. From implantable cardiac

secretion of a special protein combined with

time.

pacemakers, implantable atrial defibrillator,

these nanoparticles and deform the product.

cochlear implants, implantable electrode

The doctors of patients with cancer in the

In addition, a business of Finland has

(used for the treatment of Parkinson's

body detector scan, magnetic resonance

developed a new a new implantable insulin

disease, epilepsy and other diseases),

imaging (MRI) device on the display screen

pump use a designed for patients with type

implantable insulin pump, to all kinds of

to intuitively understand the level of activity

I diabetes. According to the developer of

plants into the stent, these products on the

of the tumor of the patient's body, and

introduction, the implantable insulin pump

market, soon to become the best-selling

accordingly formulate appropriate treatment

can change according to the blood sugar in

products in the medical device market. To

options.

diabetics automatically regulate insulin dose.

become an important branch of the medical

Implantable glucose monitors

equipment.

Zyvex Nanotechnology is a company

Implantable health information recorder

specializing in the development of the

Hypertension, coronary heart disease,

nano-bio-sensing technology. The company

diabetes, chronic obstructive pulmonary

developed a new implantable glucose monitors

disease and other chronic disease caused by

a volume of only the equivalent of an ordinary

the Governments attach great importance

button battery size. The product can be

to predict the "signs" of the disease or to

generated according to the human blood sugar

monitor changes in condition, allows people

level of the corresponding weak bioelectrical

early prevention, diagnosis and treatment of

biological change

disease, or to avoid sudden the occurrence of

of current and the

the event.

be sure, implantable medical devices has

In recent years, the research and development of a new generation of implantable medical devices developed in the United States and other developed countries in full swing, such as wireless heart monitor, real-time blood glucose monitor, remote life monitor, implantable cancer detection instrument. These have been listed or are in clinical trials of medical devices, smart, convenient shape

measured data

or use, can save the cost of medical care

form can be the

In recent years, foreign manufacturers are

miniature silicon

stepping up development of the implantable

semiconductor

electronic health information logger. Foreign

chip is transmitted

R & D personnel, these implants instruments

to the information

recorded in real time the human heartbeat,

terminal, so that

blood pressure, pulse, blood sugar and blood

doctor and patient

oxygen saturation and other important life and

can be informed of the blood glucose data in

health information, and wireless transmission

real time. The product has entered clinical

of data to the data terminal, allowing

trials.

physicians to be able to grasp the patient

and play better efficacy, even timely predict disease. "Scientific American" magazine recently reported that the incidence of cancer in countries around the world showed a rapid upward trend. How to accurately judge the efficacy and tumor progression after receiving chemotherapy, radiotherapy or surgery, is a major problem. Massachusetts Institute of Technology researchers new developed an implantable cancer detector is less than 5 mm in diameter, containing testosterone (male sex hormone) and other nanoscale protein particles. Implantation of testicular cancer, ovarian 27

changes in vital signs. Most of these new The United States GlySens newly developed a

products combined with new technologies,

new implantable glucose sensor for diabetics

nanotechnology, microelectronics, chip

provide wireless detection. This instrument

technology.

can be continuous monitoring of subcutaneous glucose levels in patients. Finger-prick compared to monitoring, the instrument

Translated from

HC3i http://www.hc3i.cn


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.